"Saint Joseph Mercy Health System (SJMHS) is a health care organization serving seven counties in southeast Michigan including Livingston, Washtenaw, Wayne, Oakland, Macomb, Jackson, and Lenawee. It includes 548-bed St. Joseph Mercy Ann Arbor, 497-bed St. Joseph Mercy Oakland in Pontiac, 304-bed St. Mary Mercy Livonia, 66-bed St. Joseph Mercy Livingston in Howell, and 133-bed St. Joseph Mercy Chelsea."

During the past decade, Saint Joseph Mercy Chelsea conducted 175 clinical trials. In the 10-year time frame, 175 clinical trials started and 38 clinical trials were completed, i.e. on average, 21.7% percent of trials that started reached the finish line to date. In the past 5 years, 93 clinical trials started and 37 clinical trials were completed. i.e. 39.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Joseph Mercy Chelsea" #1 sponsor was "National Cancer Institute (NCI)" with 86 trials, followed by "Alliance for Clinical Trials in Oncology" with 32 trials sponsored, "SWOG Cancer Research Network" with 32 trials sponsored, "NRG Oncology" with 16 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Joseph Mercy Chelsea" #1 collaborator was "National Cancer Institute (NCI)" with 100 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Genentech, Inc." with 4 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 3 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Saint Joseph Mercy Chelsea" are "Stage IV Lung Cancer AJCC v8" (16 trials), "Stage IVA Lung Cancer AJCC v8" (11 trials), "Stage IVB Lung Cancer AJCC v8" (11 trials), "Metastatic Malignant Neoplasm in the Brain" (8 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (8 trials). Many other conditions were trialed in "Saint Joseph Mercy Chelsea" in a lesser frequency.

Most popular intervention types in "Saint Joseph Mercy Chelsea" are "Drug" (148 trials), "Other" (116 trials), "Biological" (68 trials), "Procedure" (57 trials) and "Radiation" (37 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (64 trials), "Questionnaire Administration" (48 trials), "Biospecimen Collection" (35 trials), "Computed Tomography" (34 trials) and "Laboratory Biomarker Analysis" (33 trials). Other intervention names were less common.

The vast majority of trials in "Saint Joseph Mercy Chelsea" are 168 trials for "All" genders, 17 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Joseph Mercy Chelsea". undefined are not yet recruiting, 85 are recruiting, 76 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Saint Joseph Mercy Chelsea, 9 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Joseph Mercy Chelsea, 2 "Phase 1" clinical trials were conducted, 97 "Phase 2" clinical trials and 103 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".